The Company's Market Valuation Hit Rs 2,657.29 Crore.

Senores pharmaceuticals ipo listing today: Senores pharma makes a debut with over 53% premium on nse; Shares of senores pharma, a rapidly growing pharmaceutical company, made an impressive debut on the indian stock exchanges today.

Shares Of Pharmaceutical Products Manufacturer Senores Pharmaceuticals Made A Bumper Debut On The Bourses Following The Completion Of Its Initial Public Offering (Ipo).

Senores pharmaceuticals market sentiment and analysis. Promising growth strategy invites subscriber. Senores pharmaceuticals is set to make its debut with shares expected to list on 30 december 2024, at bse and nse.

Following The Bumper Debut, The Stock.

The issue is priced at ₹372 to ₹391. Strong opening followed by healthy consolidation; Senores pharmaceuticals secured ₹261 crore from prominent anchor investors ahead of the ipo launch.

Senores Pharmaceuticals Made A Healthy Stock Market Debut, With Shares Getting Listed At ₹ 600, A 53.45% Premium To Its Issue Price Of ₹391 Per Share On The Nse.

On the bse, the stock opened at rs 593.7, reflecting a 51.8% rise above its upper price band of rs 391. Ahead of the listing, the company's shares were trading at a grey. The strong listing highlights the.

Senores Pharmaceuticals Ltd Had A Successful Ipo, With Shares Surging Over 53% From The Issue Price Of Rs 391.

This positive debut comes after. Senores pharmaceuticals shares listed at 53% premium on nse and 52% premium on bse. Senores pharmaceuticals shares debuted strongly on the nse today, listing at rs 600 per share, a premium of over 53 per cent against the ipo price of rs 391.